PT Carsurin Tbk (IDX:CRSN)
107.00
-4.00 (-3.60%)
Aug 1, 2025, 4:06 PM WIB
CTI BioPharma Revenue
PT Carsurin Tbk had revenue of 117.13B IDR in the quarter ending June 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to 493.53B, up 14.60% year-over-year. In the year 2024, PT Carsurin Tbk had annual revenue of 448.51B with 0.92% growth.
Revenue (ttm)
493.53B
Revenue Growth
+14.60%
P/S Ratio
0.63
Revenue / Employee
489.13M
Employees
1,001
Market Cap
309.44B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 448.51B | 4.09B | 0.92% |
Dec 31, 2023 | 444.43B | 81.06B | 22.31% |
Dec 31, 2022 | 363.37B | 44.78B | 14.05% |
Dec 31, 2021 | 318.59B | 39.75B | 14.26% |
Dec 31, 2020 | 278.84B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PT Astra International Tbk | 333.81T |
PT Transcoal Pacific Tbk | 1,957.35B |
PT Impack Pratama Industri Tbk | 4,177.40B |
PT Jasa Marga (Persero) Tbk | 28.57T |
PT Surya Semesta Internusa Tbk | 6,228.53B |
PT Ancara Logistics Indonesia Tbk | 927.62B |
PT Wijaya Karya (Persero) Tbk | 17.57T |
PT Citra Marga Nusaphala Persada Tbk | 4,297.83B |